TardiMed Sciences LLC's Form 4 filing
Trex Wind-Down, Inc.TMBR · filed Sep 2, 2021
- Accession no.
- 0001104659-21-112596
- Filed
- Sep 2, 2021
- Trade date
- Sep 2, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $211.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TardiMed Sciences LLCCIK 0001800690 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Common Stock, par value $0.001 per share | SSaleDisposed | −225,000 | $0.94F1 | −$211,500 | 3,508,567 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9011 to $0.9971, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Referenced by the price of 1 transaction in Table I.